| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-09-18 14:56 Tx date 2026-09-15 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,775
-1,500 vol $15.85 each |
26,361 | |
| Filed 2026-09-11 17:26 Tx date 2026-09-11 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,345
-1,300 vol $15.65 each |
27,861 | |
| Filed 2026-09-11 17:23 Tx date 2026-09-11 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,138
-200 vol $15.69 each |
29,161 | |
| Filed 2026-09-11 17:22 Tx date 2026-09-10 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,650
-1,000 vol $15.65 each |
29,361 | |
| Filed 2026-09-05 11:23 Tx date 2026-09-03 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,200
-700 vol $16.00 each |
30,361 | |
| Filed 2026-09-05 11:22 Tx date 2026-09-02 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,600
-100 vol $16.00 each |
31,061 | |
| Filed 2026-09-04 17:10 Tx date 2026-08-31 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-10,400 vol |
0 | |
| Filed 2026-09-04 17:09 Tx date 2026-08-18 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,570
+1,200 vol $14.64 each |
10,400 | |
| Filed 2026-09-04 17:09 Tx date 2026-08-17 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$38,034
+2,600 vol $14.63 each |
9,200 | |
| Filed 2026-09-04 17:08 Tx date 2026-08-12 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$17,580
+1,200 vol $14.65 each |
6,600 | |
| Filed 2026-09-04 17:07 Tx date 2026-08-11 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$4,395
+300 vol $14.65 each |
5,400 | |
| Filed 2026-09-04 17:07 Tx date 2026-08-04 |
$RX
BioSyent Inc. |
BioSyent Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$74,715
+5,100 vol $14.65 each |
5,100 | |
| Filed 2026-08-28 17:11 Tx date 2026-08-28 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,200
-1,200 vol $16.00 each |
31,161 | |
| Filed 2026-08-28 17:11 Tx date 2026-08-27 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,000
-500 vol $16.00 each |
32,361 | |
| Filed 2026-08-28 17:09 Tx date 2026-08-27 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,925
-1,500 vol $15.95 each |
32,861 | |
| Filed 2026-08-28 17:08 Tx date 2026-08-26 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,925
-500 vol $15.85 each |
34,361 | |
| Filed 2026-08-28 17:07 Tx date 2026-08-25 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,700
-1,000 vol $15.70 each |
34,861 | |
| Filed 2026-08-28 11:59 Tx date 2026-08-28 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,747.98
-805 vol $15.84 each |
7,876 | |
| Filed 2026-08-28 11:54 Tx date 2026-08-28 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,158
+1,246 vol $7.35 each |
8,681 | |
| Filed 2026-08-28 11:51 Tx date 2026-08-28 |
$RX
BioSyent Inc. |
Wilton, Stephen Edwin William
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$9,158
+1,246 vol $7.35 each |